|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02197 CLOVER BIO-B
Nominal 
2.900 +0.150 (+5.455%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 3,505 | -90.877% | 38,419 | 39,255 | 0 | 0 |
| Cost of Sales | (765) | -95.458% | (16,841) | (15,014) | -- | -- |
| Gross Profit | 2,740 | -87.302% | 21,578 | 24,241 | -- | -- |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | (3,807,638) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (205,092) | -77.298% | (903,428) | (138,539) | (2,451,903) | (6,016,303) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (205,092) | -77.298% | (903,428) | (138,539) | (2,451,903) | (6,016,303) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (5,952) | -66.802% | (17,929) | 2,605 | (2,577) | (2,674) |
| Depreciation & Amortisation | 27,222 | -32.490% | 40,323 | 74,742 | 60,094 | 20,711 |
| Directors' Emoluments | -- | -- | 23,760 | 41,837 | 53,781 | 24,784 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified (Modified Report) | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -16.000 | -77.778% | -72.000 | -11.000 | -222.000 | -1,302.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.230) | (0.585) | (1.534) | (1.986) |
| NBV per share ($) | (1.385) | -- | (1.262) | (0.565) | (0.517) | 1.053 |
| Remarks: | Real time quote last updated: 27/03/2026 12:24 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -205,092 |
| %Change | -77.298% |
| EPS / (LPS) | RMB -0.160 |
| NBV Per Share (¥) | RMB -1.385 |